These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
561 related items for PubMed ID: 14730618
1. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618 [Abstract] [Full Text] [Related]
2. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H, Kawai M, Ishihara T, Suzuki N, Kuwana M. Rheumatology (Oxford); 2008 Oct; 47(10):1539-42. PubMed ID: 18687709 [Abstract] [Full Text] [Related]
3. Clinical implications of autoantibody screening in patients with autoimmune myositis. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655 [Abstract] [Full Text] [Related]
4. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Sarkar K, Weinberg CR, Oddis CV, Medsger TA, Plotz PH, Reveille JD, Arnett FC, Targoff IN, Genth E, Love LA, Miller FW. Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581 [Abstract] [Full Text] [Related]
5. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH. J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149 [Abstract] [Full Text] [Related]
6. Immune manifestations of inflammatory muscle disease. Targoff IN. Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326 [Abstract] [Full Text] [Related]
7. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG. Ann Rheum Dis; 2006 Dec; 65(12):1635-8. PubMed ID: 16679430 [Abstract] [Full Text] [Related]
9. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients. Mahler M, Greidinger EL, Szmyrka M, Kromminga A, Fritzler MJ. Ann N Y Acad Sci; 2007 Aug 30; 1109():311-21. PubMed ID: 17785320 [Abstract] [Full Text] [Related]
10. Immunoserological aspects of idiopathic inflammatory muscle disease. Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T. Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964 [Abstract] [Full Text] [Related]
11. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA. Arthritis Rheum; 2003 Jan 25; 48(1):203-9. PubMed ID: 12528120 [Abstract] [Full Text] [Related]
12. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Mammen AL. Ann N Y Acad Sci; 2010 Jan 25; 1184():134-53. PubMed ID: 20146695 [Abstract] [Full Text] [Related]
13. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Rönnelid J, Barbasso Helmers S, Storfors H, Grip K, Rönnblom L, Franck-Larsson K, Nordmark G, Lundberg IE. Autoimmun Rev; 2009 Sep 25; 9(1):58-61. PubMed ID: 19285154 [Abstract] [Full Text] [Related]
14. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome. Schilders G, Egberts WV, Raijmakers R, Pruijn GJ. Arthritis Rheum; 2007 Jul 25; 56(7):2449-54. PubMed ID: 17599775 [Abstract] [Full Text] [Related]
16. Interstitial lung disease in polymyositis and dermatomyositis. Marie I, Hachulla E, Chérin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H. Arthritis Rheum; 2002 Dec 15; 47(6):614-22. PubMed ID: 12522835 [Abstract] [Full Text] [Related]
17. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis. Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S. J Rheumatol; 2008 Mar 15; 35(3):451-7. PubMed ID: 18203319 [Abstract] [Full Text] [Related]
18. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F. Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665 [Abstract] [Full Text] [Related]
19. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O. Arthritis Rheum; 2011 Jul 01; 63(7):1961-71. PubMed ID: 21400483 [Abstract] [Full Text] [Related]
20. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. Espada G, Maldonado Cocco JA, Fertig N, Oddis CV. J Rheumatol; 2009 Nov 01; 36(11):2547-51. PubMed ID: 19833756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]